Attached files

file filename
EX-32.1 - PharMerica CORPex32_1.htm
EX-31.2 - PharMerica CORPex31_2.htm
EX-31.1 - PharMerica CORPex31_1.htm
EX-10.1 - CAREMED ID - PharMerica CORPex10_1.htm
10-Q - PharMerica CORPform10q.htm

Exhibit 32.2
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
In connection with the Quarterly Report of PharMerica Corporation (the “Corporation”) on Form 10-Q for the quarter ended March 31, 2017 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Robert E. Dries, Executive Vice President and Chief Financial Officer of the Corporation, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
 
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Corporation.
 
/s/ Robert E. Dries
 
Robert E. Dries
Executive Vice President
and Chief Financial Officer
May 10, 2017